- Home
- ROIV vs ZION Comparison
ROIV vs ZION Comparison
Compare ROIV & ZION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- ZION
- Stock Information
- Founded
- ROIV 2014
- ZION 1873
- Country
- ROIV United Kingdom
- ZION United States
- Employees
- ROIV N/A
- ZION N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- ZION Major Banks
- Sector
- ROIV Health Care
- ZION Finance
- Exchange
- ROIV Nasdaq
- ZION Nasdaq
- Market Cap
- ROIV 8.4B
- ZION 7.4B
- IPO Year
- ROIV N/A
- ZION N/A
- Fundamental
- Price
- ROIV $10.64
- ZION $46.51
- Analyst Decision
- ROIV Buy
- ZION Hold
- Analyst Count
- ROIV 4
- ZION 20
- Target Price
- ROIV $17.50
- ZION $58.26
- AVG Volume (30 Days)
- ROIV 6.2M
- ZION 1.8M
- Earning Date
- ROIV 05-29-2025
- ZION 04-21-2025
- Dividend Yield
- ROIV N/A
- ZION 3.69%
- EPS Growth
- ROIV N/A
- ZION 28.95
- EPS
- ROIV N/A
- ZION 5.12
- Revenue
- ROIV $122,585,000.00
- ZION $3,106,000,000.00
- Revenue This Year
- ROIV N/A
- ZION $9.32
- Revenue Next Year
- ROIV N/A
- ZION $4.34
- P/E Ratio
- ROIV N/A
- ZION $9.11
- Revenue Growth
- ROIV 140.04
- ZION 6.44
- 52 Week Low
- ROIV $8.73
- ZION $39.32
- 52 Week High
- ROIV $13.06
- ZION $63.22
- Technical
- Relative Strength Index (RSI)
- ROIV 47.30
- ZION 53.11
- Support Level
- ROIV $11.02
- ZION $45.25
- Resistance Level
- ROIV $11.77
- ZION $47.21
- Average True Range (ATR)
- ROIV 0.33
- ZION 1.43
- MACD
- ROIV -0.02
- ZION 0.44
- Stochastic Oscillator
- ROIV 28.93
- ZION 91.01
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About ZION Zions Bancorporation N.A.
Zions Bancorporation is a regional us bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.